ArticleScientific reports2025

Beta-adrenergic receptor blockers improve survival in patients with advanced non-small cell lung cancer combined with hypertension undergoing radiotherapy.

Xinyi Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.